Search: onr:"swepub:oai:lup.lub.lu.se:1e0aab87-e13a-47c4-b51b-13a4009f4a5f" > The LKB1-salt-induc...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 03530naa a2200541 4500 | |
001 | oai:lup.lub.lu.se:1e0aab87-e13a-47c4-b51b-13a4009f4a5f | |
003 | SwePub | |
008 | 160401s2014 | |||||||||||000 ||eng| | |
024 | 7 | a https://lup.lub.lu.se/record/46156222 URI |
024 | 7 | a https://doi.org/10.1038/ncomms55352 DOI |
040 | a (SwePub)lu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a art2 swepub-publicationtype |
072 | 7 | a ref2 swepub-contenttype |
100 | 1 | a Patel, Kashyap4 aut |
245 | 1 0 | a The LKB1-salt-inducible kinase pathway functions as a key gluconeogenic suppressor in the liver. |
264 | c 2014-08-04 | |
264 | 1 | b Springer Science and Business Media LLC,c 2014 |
338 | a electronic2 rdacarrier | |
520 | a LKB1 is a master kinase that regulates metabolism and growth through adenosine monophosphate-activated protein kinase (AMPK) and 12 other closely related kinases. Liver-specific ablation of LKB1 causes increased glucose production in hepatocytes in vitro and hyperglycaemia in fasting mice in vivo. Here we report that the salt-inducible kinases (SIK1, 2 and 3), members of the AMPK-related kinase family, play a key role as gluconeogenic suppressors downstream of LKB1 in the liver. The selective SIK inhibitor HG-9-91-01 promotes dephosphorylation of transcriptional co-activators CRTC2/3 resulting in enhanced gluconeogenic gene expression and glucose production in hepatocytes, an effect that is abolished when an HG-9-91-01-insensitive mutant SIK is introduced or LKB1 is ablated. Although SIK2 was proposed as a key regulator of insulin-mediated suppression of gluconeogenesis, we provide genetic evidence that liver-specific ablation of SIK2 alone has no effect on gluconeogenesis and insulin does not modulate SIK2 phosphorylation or activity. Collectively, we demonstrate that the LKB1-SIK pathway functions as a key gluconeogenic gatekeeper in the liver. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Endokrinologi och diabetes0 (SwePub)302052 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Endocrinology and Diabetes0 (SwePub)302052 hsv//eng |
700 | 1 | a Foretz, Marc4 aut |
700 | 1 | a Marion, Allison4 aut |
700 | 1 | a Campbell, David G4 aut |
700 | 1 | a Gourlay, Robert4 aut |
700 | 1 | a Boudaba, Nadia4 aut |
700 | 1 | a Tournier, Emilie4 aut |
700 | 1 | a Titchenell, Paul4 aut |
700 | 1 | a Peggie, Mark4 aut |
700 | 1 | a Deak, Maria4 aut |
700 | 1 | a Wan, Min4 aut |
700 | 1 | a Kaestner, Klaus H4 aut |
700 | 1 | a Göransson, Olgau Lund University,Lunds universitet,Proteinfosforylering,Forskargrupper vid Lunds universitet,Protein Phosphorylation,Lund University Research Groups4 aut0 (Swepub:lu)medk-ogo |
700 | 1 | a Viollet, Benoit4 aut |
700 | 1 | a Gray, Nathanael S4 aut |
700 | 1 | a Birnbaum, Morris J4 aut |
700 | 1 | a Sutherland, Calum4 aut |
700 | 1 | a Sakamoto, Kei4 aut |
710 | 2 | a Proteinfosforyleringb Forskargrupper vid Lunds universitet4 org |
773 | 0 | t Nature Communicationsd : Springer Science and Business Media LLCg 5:Aug 4q 5:Aug 4x 2041-1723 |
856 | 4 | u https://portal.research.lu.se/files/4288635/7864277x primaryx freey FULLTEXT |
856 | 4 | u http://www.ncbi.nlm.nih.gov/pubmed/25088745?dopt=Abstractx freey FULLTEXT |
856 | 4 | u http://dx.doi.org/10.1038/ncomms5535x freey FULLTEXT |
856 | 4 | u https://www.nature.com/articles/ncomms5535.pdf |
856 | 4 8 | u https://lup.lub.lu.se/record/4615622 |
856 | 4 8 | u https://doi.org/10.1038/ncomms5535 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Copy and save the link in order to return to this view